The new European regulations for the development, manufacture, marketing and product monitoring of medical devices within the EU in the form of the MDR and IVDR require manufacturers to store product and manufacturer-related data in the EUDAMED database. EUDAMED is considered by industry experts to be a key element of the new regulatory framework and is intended in particular to improve market surveillance, ensure the exchange of information on clinical trial data and contribute to the uniform application of the regulations.
The original plan was for manufacturers and other economic operators to enter their data into the EUDAMED database when the MDR came into force on 26 May 2020. The European legislator had provided for an 18-month transition period during which manufacturers were to record all relevant data on their products (including those still marketed under the MDD).
This week, what had been looming and feared for some time has now been confirmed: the go-live date for EUDAMED has been postponed by a full two years.
The reasons given for the postponement of the planned launch date are necessary improvements to the database. The planned improvements mean that the database cannot be put into operation until the entire system and its modules have reached full functionality and have undergone independent testing. The activation of individual modules is therefore to be refrained from. The market launch of EUDAMED for medical devices and in vitro medical devices together is now scheduled for the date originally planned for the IVDR, namely 26 May 2022.
Impact of the postponement on manufacturers
Despite its importance within the MDR regulatory framework, this postponement of the launch date of EUDAMED has no impact on the date of application of the MDR itself. Regardless of demands from industry, 26 May 2020 is still the planned date of application. Manufacturers are therefore still well advised to make their companies and products MDR-compliant in order to be ready for the MDR launch date and to be able to continue marketing their products. Registration within Germany will initially continue via the DIMDI database.
back